| Today, Tue, Nov 24, 2009 | | • | Forgetful patients lift support consultancies
at FT.com (Tue 6:05pm)
| | • | Seven Dividend Stocks to Take the Emotion Out of Investing
at Seeking Alpha (Tue 1:59pm)
| | Mon, Nov 23, 2009 | | • | Good News for Bristol-Myers
Zacks.com (Mon 9:07am)
| | • | [$$] Sanofi Has Lots of Upside Catalysts
at RealMoney by TheStreet.com (Mon 8:12am)
| | Fri, Nov 20, 2009 | | • | Worse Than You Think
at Forbes.com (Fri, Nov 20)
| | • | Big Pharma Mergers: Good News Or Bad?
Investor's Business Daily (Fri, Nov 20)
| | • | This Baby Is a Nice Addition
at Motley Fool (Fri, Nov 20)
| | • | 5 Signs of a Strong Dividend Stock
at Motley Fool (Fri, Nov 20)
| | • | Cramer's Top 5 Dividend Plays
at CNBC (Fri, Nov 20)
| | • | Health Fraud Caseload Grows at Justice Department
at The Wall Street Journal Online (Fri, Nov 20)
| | • | AstraZeneca Seeks FDA Approval
Zacks.com (Fri, Nov 20)
| | • | Trading Review for Vivus Inc. Issued by Beacon Equity
GlobeNewswire (Fri, Nov 20)
| | • | Competition in Blood-Thinners: Win-Win for Everyone Involved
at Seeking Alpha (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | • | For Lilly's R&D Chief, a $2 Million Exit Handshake
at The Wall Street Journal Online (Thu, Nov 19)
| | • | AstraZeneca Enters the Race for the Next Plavix
at Minyanville.com (Thu, Nov 19)
| | • | Big Pharma Under Pressure as Drug Patents Expire and Pipeline Slows
at Seeking Alpha (Thu, Nov 19)
| | • | UPDATE - EU panel blocks Merck KGaA's Erbitux in lung cancer
at Reuters (Thu, Nov 19)
| | • | Moody's gives negative view on pharma credit
AP (Thu, Nov 19)
| | • | UPDATE - Healthcare stocks not unduly hurt by Senate plan
at Reuters (Thu, Nov 19)
| | • | LILLY ELI & CO Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Thu, Nov 19)
|
Add LLY News to My Yahoo!:
 
| |
|
0.16% Nasdaq 
0.50 (1.36%) 
Headlines
